Myriad Genetics MYGN Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$399.9M-9.3% | -$365.9M+8.6% | -$400.5M-1.3% | -$395.2M-290% | -$101.4M+20.3% | ||
| $51.8M-3.5% | $53.7M-3.9% | $55.9M-5.1% | $58.9M-1.7% | $59.9M-2.1% | ||
| $32.2M-8.5% | $35.2M-18.7% | $43.3M-0.5% | $43.5M-8.0% | $47.3M-5.0% | ||
| $324.8M+1.7% | $319.4M-11.2% | $359.7M-0.2% | $360.5M+551% | $55.4M-2.1% | ||
| $3.3M+153% | -$6.2M— | —— | —— | —— | ||
| —— | —— | $5.4M+116% | $2.5M-52.8% | $5.3M-14.5% | ||
| $4M+386% | -$1.4M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$1M+50.0% | -$2M-33.3% | -$1.5M— | $0+100% | -$300K— | ||
| $4.3M+19.4% | $3.6M+71.4% | $2.1M+133% | $900K— | —— | ||
| $5.9M-23.4% | $7.7M-18.1% | $9.4M-12.1% | $10.7M+7.0% | $10M+5.3% | ||
| $2.4M+33.3% | $1.8M— | —— | —— | —— | ||
| $9.9M-16.1% | $11.8M-7.8% | $12.8M+4.9% | $12.2M+3.4% | $11.8M+10.3% | ||
| -$25.6M+6.6% | -$27.4M-0.4% | -$27.3M— | —— | —— | ||
| —— | —— | —— | —— | $100M-16.7% | ||
| —— | —— | —— | —— | $80M-33.1% | ||
| —— | —— | $400K0.0% | $400K0.0% | $400K0.0% | ||
| $4.4M-39.7% | $7.3M0.0% | $7.3M-27.0% | $10M-4.8% | $10.5M-21.6% | ||
| —— | —— | —— | —— | —— | ||
| $600K-25.0% | $800K— | $0— | —— | —— | ||
| $28.5M-33.6% | $42.9M— | —— | —— | —— | ||
| $324.8M+1.7% | $319.4M-11.2% | $359.7M-0.2% | $360.5M— | —— | ||
| $7.3M+3,750% | -$200K— | —— | —— | —— | ||
| -$12.3M-180% | -$4.4M-37.5% | -$3.2M— | —— | —— | ||
| $63.8M+96.3% | $32.5M+192% | -$35.2M-0.9% | -$34.9M-1.5% | -$34.4M-1,276% | ||
| $5.9M-23.4% | $7.7M-18.1% | $9.4M-12.1% | $10.7M+7.0% | $10M+5.3% | ||
| $9.9M-16.1% | $11.8M-7.8% | $12.8M+4.9% | $12.2M+3.4% | $11.8M+10.3% | ||
| $15.7M+0.6% | $15.6M+7.6% | $14.5M-4.6% | $15.2M-13.6% | $17.6M-7.4% | ||
| —— | —— | $400K0.0% | $400K0.0% | $400K0.0% | ||
| —— | $7.5M+33.3% | $5.63M+50.0% | $3.75M+100% | $1.88M— | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | -$200K+20.0% | -$250K+16.7% | -$300K+14.3% | -$350K+12.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Myriad Genetics generate?
- Myriad Genetics (MYGN) generated $2.4M in operating cash flow over the trailing twelve months.
- Where does Myriad Genetics's cash flow data come from?
- Every line is extracted from Myriad Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
